Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

Shlaes, David M.; Gerding, Dale N.; John, Joseph F.; Craig, William A.; Bornstein, Donald L.; Duncan, Robert A.; Eckman, Mark R.; Farrer, William; Greene, William H.; Lorian, Víctor; Levy, Stuart B.; McGowan, John E.; Paul, Sindy M.; Ruskin, Joel; Tenover, Fred C.; Watanakunakorn, Chatrchai

doi:10.1086/647610

Cited by 327 publications

(327 citation statements)

References 79 publications

Supporting

Mentioning

295

Contrasting

Unclassified

Order By: Relevance

“…29 ' 30 ' 34 The Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) recognized these needs in 1997 with the publication of "Guidelines for the Prevention of Antimicrobial Resistance in Hospitals." 31,32 In 2007, these societies promoted the concept of antimicrobial stewardship when they issued "Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship," 33 which discusses the development of multidisciplinary teams in acute care settings to review and improve antimicrobial use and improve patient care. A recent IDSA policy paper titled "Combating Antimicrobial Resistance: Policy Recommendations to Save Lives" has been issued.…”

Section: Infect Control Hosp Epidemiol 2012;33(4):322-327mentioning

confidence: 99%

Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)

Fishman¹

2012

Infect. Control Hosp. Epidemiol.

586

249

View full text Add to dashboard Cite

Antimicrobial resistance has emerged as a significant healthcare quality and patient safety issue in the twenty-first century that, combined with a rapidly dwindling antimicrobial armamentarium, has resulted in a critical threat to the public health of the United States. Antimicrobial stewardship programs optimize antimicrobial use to achieve the best clinical outcomes while minimizing adverse events and limiting selective pressures that drive the emergence of resistance and may also reduce excessive costs attributable to suboptimal antimicrobial use. Therefore, antimicrobial stewardship must be a fiduciary responsibility for all healthcare institutions across the continuum of care. This position statement of the Society for Healthcare Epidemiology of America, the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society of America outlines recommendations for the mandatory implementation of antimicrobial stewardship throughout health care, suggests process and outcome measures to monitor these interventions, and addresses deficiencies in education and research in this field as well as the lack of accurate data on antimicrobial use in the United States.

show abstract

Section: Infect Control Hosp Epidemiol 2012;33(4):322-327mentioning

confidence: 99%

Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)

Fishman¹

2012

Infect. Control Hosp. Epidemiol.

586

249

View full text Add to dashboard Cite

show abstract

“…Various strategies have been proposed with the aim of moderating the emergence of bacterial resistance in the hospital environment [4][5][6]. However, the success of such measures depends largely on the availability of information regarding the form in which antibiotics are administered and salient factors relating to their excessive or inadequate use, particularly in ICUs.…”

mentioning

confidence: 99%

Use of antibacterial agents in an intensive care unit in a hospital in Brazil

Santos¹,

Lauria-Pires²,

Pereira³

et al. 2007

Braz J Infect Dis

View full text Add to dashboard Cite

“…A number of factors contribute to this, including the severity of patient illness, predisposition to nosocomial infections, cross-transmission of pathogens characteristic of ward areas within the hospital, and the widespread use of prophylactic and therapeutic anti-infective agents. Appropriate therapy of these infections directed by local resistance data can have significant consequences for both patients and the healthcare system [14][15][16].…”

Section: Discussionmentioning

confidence: 99%

Bacterial pericarditis and antimicrobial resistance at the Tehran Heart Center, Iran

Anvari

Kianinejad

Boroumand

et al. 2015

J Infect Dev Ctries

View full text Add to dashboard Cite

Introduction: When bacterial pericarditis is suspected, urgent pericardial drainage combined with intravenous antibacterial therapy is mandatory to avert devastating, life-threatening complications. There have been scanty results on antimicrobial susceptibility of common causative microorganisms of bacterial pericarditis; most studies had small sample sizes and were performed decades ago. Methodology: This prospective study surveyed the causative bacteria in infectious pericardial effusions and their antimicrobial susceptibility among 320 consecutive cardiac patients who underwent pericardiocentesis at Tehran Heart Center between 2007 and 2012, using the European Society of Cardiology (ESC)'s criteria. Results: Staphylococcus spp. (S. epidermidis, S. aureus, S. haemolyticus) were the main causative organisms isolated from cultures of pericardial effusion samples. Other causative organisms were Streptococcus spp., Enterococcus faecium, Pseudomonas aeruginosa, and Acinetobacter baumannii. In the cultures studied, 35% methicillin-resistant Staphylococcus epidermidis (MRSE) and 42.9% methicillinresistant Staphylococcus aureus (MRSA) were detected. The most effective antimicrobial agents in S. epidermidis were gentamicin, ciprofloxacin, and cefoxitin. Clindamycin was relatively effective. S. aureus was highly susceptible to clindamycin and erythromycin. In cases of S. haemolyticus infection, clindamycin, erythromycin, cefoxitin, and ciprofloxacin were effective antibiotics. Conclusions: In order to diminish the nascence and extension of antimicrobial-resistant pathogens, logical and optimized antimicrobial usage and monitoring in hospitals are highly recommended. It is incumbent on healthcare systems to determine current local resistance patterns by which to guide empiric antimicrobial therapy for specific infections and microorganism types.

show abstract

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

Cited by 327 publications

References 79 publications

Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)

Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)

Use of antibacterial agents in an intensive care unit in a hospital in Brazil

Bacterial pericarditis and antimicrobial resistance at the Tehran Heart Center, Iran

Contact Info

Product

Resources

About